Joseph Wagner
Plus aucun poste en cours
Fortune : - $ au 31/05/2024
Profil
Dr. Joseph P.
Wagner is a Chief Scientific Officer at Notable Labs Ltd.
Dr. Wagner was previously employed as a President, Chief Executive Officer & Director by BriaCell Therapeutics Corp., a President by Cell Targeting, Inc., a Vice President-Cellular Therapy by Neuronyx, Inc., and a Chief Executive Officer by OncoCyte Corp.
He received his undergraduate degree from Rochester Christian University and a doctorate degree from Duke University School of Medicine.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
-.--% | 08/05/2024 | 0 ( -.--% ) | - $ | 31/05/2024 |
Postes actifs de Joseph Wagner
| Sociétés | Poste | Début |
|---|
Anciens postes connus de Joseph Wagner
| Sociétés | Poste | Fin |
|---|---|---|
| BRIACELL THERAPEUTICS CORP. | Directeur Général | 24/03/2016 |
Neuronyx, Inc.
 Neuronyx, Inc. Medical SpecialtiesHealth Technology Neuronyx, Inc. develops and distributes bone marrow derived stem cells. It also develops cellular therapies focusing on ischemic diseases to repair damaged cardiac tissues in patients suffering from heart attack. The company was founded by Hubert J.P. Schoemaker in 1999 and is located in Malvern, PA. | Corporate Officer/Principal | 13/10/2009 |
Cell Targeting, Inc.
 Cell Targeting, Inc. BiotechnologyHealth Technology Part of Lineage Cell Therapeutics, Inc., Cell Targeting, Inc. is a company that provides research and development of aqueous-based synthetic solutions. The company is based in Cleveland, OH. Cell Targeting was acquired by Lineage Cell Therapeutics, Inc. on January 28, 2011 for $2.38 million. | President | - |
| ONCOCYTE CORPORATION | Directeur Général | - |
Formation de Joseph Wagner
| Rochester Christian University | Undergraduate Degree |
| Duke University School of Medicine | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| ONCOCYTE CORPORATION | Health Technology |
| BRIACELL THERAPEUTICS CORP. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Neuronyx, Inc.
Neuronyx, Inc. Medical SpecialtiesHealth Technology Neuronyx, Inc. develops and distributes bone marrow derived stem cells. It also develops cellular therapies focusing on ischemic diseases to repair damaged cardiac tissues in patients suffering from heart attack. The company was founded by Hubert J.P. Schoemaker in 1999 and is located in Malvern, PA. | Health Technology |
Cell Targeting, Inc.
Cell Targeting, Inc. BiotechnologyHealth Technology Part of Lineage Cell Therapeutics, Inc., Cell Targeting, Inc. is a company that provides research and development of aqueous-based synthetic solutions. The company is based in Cleveland, OH. Cell Targeting was acquired by Lineage Cell Therapeutics, Inc. on January 28, 2011 for $2.38 million. | Health Technology |
